Acorn Capital Advisors, LLC

Bedrift	Dele, %
Puma Biotechnology, Inc.	8.12
BioAtla, Inc.	6.51
Jasper Therapeutics, Inc.	6.38
Candel Therapeutics, Inc.	4.7
Q32 Bio Inc	4.01
Protara Therapeutics, Inc.	3.39
Cybin Inc.	2.92
Cardiff Oncology, Inc.	2.87
Acrivon Therapeutics, Inc.	1.28